膝関節炎治療におけるヒアルロン酸の世界市場：市場規模、シェア、トレンド分析レポート – 業界概要と2032年までの予測

Customize Your Report レポートをカスタマイズする Buy Now 今すぐ購入 Free Sample Report 無料サンプルレポート
Home Healthcare Global Hyaluronic Acid Market For Knee Osteoarthritis Treatment Market
Request for TOC TOC のリクエスト Speak to Analyst アナリストに相談する Free Sample Report 無料サンプルレポート Inquire Before Buying 事前に問い合わせる Buy Now今すぐ購入

膝関節炎治療におけるヒアルロン酸の世界市場：市場規模、シェア、トレンド分析レポート – 業界概要と2032年までの予測

  • Healthcare
  • Published Report
  • Apr 2025
  • Global
  • 350 ページ
  • テーブル数: 500
  • 図の数: 48
  • Author : Sachin Pawar
Buy Now 今すぐ購入 Request for Sample 無料サンプルPDFをダウンロード
Nucleus Nucleus

アジャイルなサプライチェーンコンサルティングで関税の課題を回避

サプライチェーンエコシステム分析は、現在DBMRレポートの一部です

膝関節炎治療におけるヒアルロン酸の世界市場：市場規模、シェア、トレンド分析レポート

Market Size in USD Billion

CAGR :  % Diagram

Chart Image USD 2.28 Billion USD 4.29 Billion 2024 2032
Diagram 予測期間
 2025 –2032
Diagram 市場規模（基準年）
 USD 2.28 Billion
Diagram Market Size (Forecast Year)
 USD 4.29 Billion
Diagram CAGR
 %
Diagram Major Markets Players
  • LG Chem
  • Bioventus LLC
  • Seikagaku Corporation

膝関節症治療のためのヒアルロン酸の世界市場：市場区分、製品タイプ別（単回注入（モノファジック）、3回注入レジメン（トリファジック）、5回注入レジメン（ペンタファジック））、処方別（架橋ヒアルロン酸、非架橋ヒアルロン酸）、分子量別（高分子量（HMW）ヒアルロン酸、低分子量（LMW）ヒアルロン酸、中分子量ヒアルロン酸）、治療目標別（粘性補充療法、抗炎症および鎮痛、軟骨保護および再生）、エンドユーザー別（病院、整形外科クリニック、外来手術センター、専門疼痛管理センター）、流通チャネル別（直接入札、小売およびオンライン薬局、その他）、国別（米国、カナダ、メキシコ、ドイツ、フランス、英国、イタリア、ロシア、スペイン、トルコ、オランダ、スイス、ベルギー、スウェーデン、オーストリア、デンマーク、ノルウェー、ポーランド、その他のヨーロッパ諸国、中国、インド、日本、韓国、オーストラリア、インドネシア、タイ、マレーシア、ベトナム、フィリピン、台湾、シンガポール、ニュージーランド、フィリピン、カザフスタン、ブルネイ、その他のアジア太平洋諸国、サウジアラビア、南アフリカ、エジプト、UAE、イスラエル、クウェート、カタール、イラン、オマーン、アルジェリア、ナイジェリア、イラク、モロッコ、ケニア、ガーナ、チュニジア、タンザニア、ヨルダン、リビア、バーレーン、アンゴラ、カメルーン、コートジボワール、ジンバブエ、セネガル、モーリタニア、トーゴ、モーリシャス、ボツワナ、その他の中東およびアフリカ諸国、ブラジル、アルゼンチン、チリ、ペルー、コロンビア、エクアドル、ベネズエラ、パナマ、ウルグアイ、ドミニカ共和国、その他の南米諸国 - 2032年までの業界動向と予測

膝関節炎治療市場におけるヒアルロン酸市場

 膝関節炎治療におけるヒアルロン酸市場規模

  • 膝関節炎治療のためのヒアルロン酸の世界市場は、2024年に22億8000万米ドルと評価され、 2032年までに42億9000万米ドルに達すると予想されています。
  • 2025年から2032年の予測期間中、市場は主に予想される治療法の発売によって8.3％のCAGRで成長する可能性が高い。
  • 変形性膝関節症の罹患率の上昇と低侵襲治療への関心の高まりにより、ヒアルロン酸をベースとした治療法の需要が高まっています。さらに、粘性補充療法のメリットに対する認知度の高まりも、市場の成長をさらに促進しています。

膝関節炎治療市場におけるヒアルロン酸市場膝関節炎治療市場におけるヒアルロン酸市場

膝関節炎治療におけるヒアルロン酸市場分析

  • ヒアルロン酸は体内に自然に存在する物質で、特に結合組織、皮膚、そして関節を潤滑する滑液に多く含まれています。変形性膝関節症の治療において、ヒアルロン酸は粘性補充剤として関節機能の改善と疼痛緩和に用いられています。ヒアルロン酸を膝関節に直接注入することで、クッション効果を高め、運動時の摩擦を軽減し、軟骨の再生を促進することで、変形性関節症の症状緩和をもたらします。この治療は、可動域の回復、生活の質の向上、そして病気の進行を遅らせることを目指しています。
  • 北米は、確立された医療制度と、高度な非外科的関節ケアオプションの採用率の高さにより、膝関節炎治療用のヒアルロン酸市場における主要地域として浮上しています。
    • 例えば、米国では、患者の意識の高まりと有利な償還政策に支えられ、関節内ヒアルロン酸注射の採用が急増している。
  • この地域では、変形性関節症患者の運動機能と生活の質の向上に重点を置いており、ヒアルロン酸ベースの治療法の革新と市場拡大を推進し続けています。

膝関節炎治療におけるヒアルロン酸市場レポートの適用範囲とセグメンテーション

属性

膝関節炎治療におけるヒアルロン酸市場：主要市場インサイト

対象セグメント
  • 製品タイプ別：単回注射（単相性）、3回注射レジメン（三相性）、5回注射レジメン（五相性）
  • 配合成分： 架橋ヒアルロン酸、非架橋ヒアルロン酸
  • 分子量別： 高分子量（HMW）HA、低分子量（LMW）HA、中分子量HA
  • 治療目標別： 粘性補充療法、抗炎症および鎮痛、軟骨保護および再生
  • エンドユーザー別: 病院、整形外科クリニック、外来手術センター、専門疼痛管理センター
  • 流通チャネル別：直接入札、小売・オンライン薬局、その他

対象国

北米

  • シラミ
  • カナダ
  • メキシコ

ヨーロッパ

  • ドイツ
  • フランス
  • 英国
  • イタリア
  • ロシア
  • スペイン
  • 七面鳥
  • オランダ
  • スイス
  • ベルギー
  • スウェーデン
  • オーストリア
  • デンマーク
  • ノルウェー
  • ポーランド
  •  その他のヨーロッパ

アジア太平洋

  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア
  • インドネシア
  • タイ
  • マレーシア
  • ベトナム
  • フィリピン
  • 台湾
  • シンガポール
  • ニュージーランド
  • フィリピン
  • カザフスタン
  • ブルネイ
  • その他のアジア太平洋地域

中東およびアフリカ

  • サウジアラビア
  • 南アフリカ
  • エジプト
  • アラブ首長国連邦
  • イスラエル
  • クウェート
  • カタール
  • イラン
  • オマーン
  • アルジェリア
  • ナイジェリア
  • イラク
  • モロッコ
  • ケニア
  • ガーナ
  • チュニジア
  • タンザニア
  • ヨルダン
  • リビア
  • バーレーン
  • アンゴラ
  • カメルーン
  • コートジボワール
  • ジンバブエ
  • セネガル
  • モーリタニア
  • 持ち帰り
  • モーリシャス
  • ボツワナ
  • その他の中東およびアフリカ

南アメリカ

  • ブラジル
  • アルゼンチン
  • チリ
  • ペルー
  • コロンビア
  • エクアドル
  • ベネズエラ
  • パナマ
  • ウルグアイ
  • ドミニカ共和国
  • 南アメリカのその他の地域

主要な市場プレーヤー
  • LG化学（韓国）
  • バイオベンタスLLC（米国）
  • Seikagaku Corporation (Japan)
  • サノフィ（フランス）
  • アニカ・セラピューティクス社（米国）
  • IBSA Biochemical Institute SA (スイス)
  • ビアトリス（米国）
  • ジマー・バイオメット（米国）
  • フィディア・ファーマセウチSpA（イタリア）
  • フェリング・ファーマシューティカルズ（スイス）
  • TRB CHEMEDICA SA（スイス）
  • 杭州星清医療製品有限公司（中国）
  • ハンミ製薬株式会社（韓国）
  • ヴィルショウ・バイオテック（インド）
  • ユープラクシア・ファーマシューティカルズ（カナダ）

市場機会
  • ヒアルロン酸製剤と送達システムの進歩
  • 医師と患者の間で、膝関節炎治療におけるヒアルロン酸の認知度と受容度を高める

付加価値データ情報セット

データブリッジマーケットリサーチがまとめた市場レポートには、市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、輸出入分析、生産能力の概要、生産消費分析、価格動向分析、気候変動シナリオ、サプライチェーン分析、バリューチェーン分析、原材料/消耗品の概要、ベンダー選択基準、PESTLE分析、ポーター分析、規制枠組みも含まれています。

膝関節炎治療におけるヒアルロン酸市場動向

「低侵襲性および標的治療への関心の高まり」

  • 膝関節炎治療のためのヒアルロン酸の世界市場における重要な傾向として、低侵襲でターゲットを絞った治療オプションがますます好まれるようになっています。
  • ヒアルロン酸注射は粘性補充療法としても知られ、外科的介入を必要とせずに局所的な痛みの緩和と関節可動性の改善をもたらすため、患者と臨床医の両方にとって非常に魅力的です。
  • 例えば、 患者のニーズに合わせて調整された単回および複数回の注射製剤が普及し、治療計画に柔軟性と利便性をもたらしている。
  • この傾向は、注射技術の進歩、製剤の安定性の向上、治療効果の持続期間の延長によってさらに裏付けられています。
  • さらに、超音波ガイド下注射などの画像技術を統合することで、精度と患者の快適性が向上します。
  • 非外科的、効果的、そして患者中心の治療オプションへの移行は、変形性膝関節症治療の未来を形作り、ヒアルロン酸市場の成長を促進します。

膝関節炎治療におけるヒアルロン酸市場の動向

ドライバ

「膝関節炎の有病率の増加」

  • 世界人口の高齢化が進むにつれ、軟骨の破壊を特徴とする変形性関節症の有病率は大幅に増加すると予想されています。この人口動態の傾向は特に憂慮すべきものです。変形性関節症は慢性的な痛み、こわばり、可動性の低下といった症状を引き起こし、患者の生活の質に深刻な影響を与える可能性があるからです。変形性関節症の発症率の上昇に伴い、多くの患者が侵襲的な外科手術に代わる治療法を求めており、効果的な治療法への需要が急増しています。ヒアルロン酸（HA）注射は、患部の関節に潤滑油を供給し、関節機能と可動性を向上させることで症状を効果的に緩和する、低侵襲治療として非常に人気が高まっています。
  • これらの注射は、関節液中の天然ヒアルロン酸を補充することで、関節間の摩擦を軽減し、衝撃吸収性を高めることで効果を発揮します。この二重の作用は、痛みを和らげるだけでなく、関節全体の健康状態を改善するため、患者と医療従事者の両方にとって魅力的な選択肢となっています。

例えば、

  • 2023年12月、NCBIは、世界中でOAの有病率が高く、高齢者、女性、一部の人種・民族、そして社会経済的地位の低い人々において大きな負担となっていることが研究によって引き続き示されていると述べました。OAの修正可能なリスク要因として最も有力な証拠があるのは、肥満と関節損傷です。
  • 2024年11月、Frontiers誌に掲載された記事によると、インドの研究では、年齢層を問わずKOAの有病率が上昇していることが報告されており、50歳未満では19.2%、50～60歳では30.7%、60～70歳では39.7%、70歳以上では54.1%となっている(23)。別の研究では、55歳を過ぎると変形性膝関節症の有病率と発症率の両方が大幅に上昇することが明らかになった。55歳以上の人の平均有病率は13.2%で、男性では9.4%、女性では18.0%となっている。
  • ヒアルロン酸の効能に対する認識の高まりは、医療従事者と患者双方におけるヒアルロン酸の導入を促進しています。臨床研究において、変形性膝関節症の患者の痛みを軽減し、生活の質を向上させるヒアルロン酸の有効性が実証され続けていることから、より多くの医療従事者がこれらの治療法を診療に取り入れています。こうしたヒアルロン酸の認知度向上と変形性膝関節症の症例増加は、市場の成長に好ましい環境を生み出し、メーカー間のイノベーションと競争を促進し、ヒアルロン酸療法のための高度な処方と投与方法の開発を促進しています。

膝関節炎治療市場におけるヒアルロン酸市場

機会

「ヒアルロン酸製剤と送達システムの進歩」

  • 改良された高分子量・架橋ヒアルロン酸製品は、より持続的な鎮痛効果をもたらし、注射回数も少なくて済みます。これは、症状管理のための効果的かつ簡便なソリューションを求める患者にとって魅力的です。ハイドロゲルやナノ粒子システムといった革新的な送達方法は、関節におけるヒアルロン酸の耐久性と効果を高めます。これらの開発は、高齢化社会における高まる需要に応えています。企業はこれらの技術を活用することで、競争の激しい市場で差別化を図り、より多くの顧客を獲得することができます。治療頻度の低減と患者の転帰改善に重点を置くことで、市場の成長ポテンシャルが高まります。そのため、変形性膝関節症治療におけるヒアルロン酸分野は、投資と事業拡大にとって非常に魅力的な分野となっています。

例えば、

  • IBSA Institut Biochimique SA、サノフィ、生化学工業株式会社によると、各社は関節の潤滑性、疼痛緩和、治療の持続性を高める独自の製剤を開発しています。これらの革新は、保持力の向上、架橋技術、そして患者の利便性に焦点を当てており、持続的な症状緩和を実現します。
  • 2024年4月、ScienceDirectの記事では、変形性関節症の薬剤送達に用いられるヒアルロン酸ベースのリポソームにおいて、カップリング化学を用いたリポソーム調製後の表面機能化、または還元アミノ化によるヒアルロン酸-脂質複合体の合成が注目されました。これらの方法は、生体適合性を向上させ、様々な薬剤の同時送達を可能にし、複合体形成の制御性を高め、効果的な関節炎治療のためのリポソームシステムを最適化します。
  • ヒアルロン酸製剤と送達システムの進歩は、変形性膝関節症治療の有効性と利便性を著しく向上させます。製品寿命の延長と注射頻度の低減により、これらのイノベーションは高齢化社会における低侵襲ソリューションへの高まる需要に応えます。これらの技術を採用する企業は、市場でのプレゼンスを強化し、より多くの患者を惹きつけ、業界の成長を捉えることができます。そのため、ヒアルロン酸をベースとした治療への投資は、進化する医療環境において長期的な成功を実現するための戦略的機会となります。

抑制/挑戦

「膝関節炎におけるヒアルロン酸療法のコスト関連の課題とアクセスに関する懸念」

  • 変形性膝関節症に対するヒアルロン酸（HA）注射は、特に保険適用外、あるいは全額補償されない場合、非常に高額になることがあります。この経済的負担により、患者は自己負担を強いられることが多く、特に経済的に余裕のない患者にとっては大きな負担となる可能性があります。
  • さらに、長期間にわたり複数回の注射が必要となる場合があり、治療費が増大します。その結果、痛みを軽減し関節機能を改善する可能性を秘めているにもかかわらず、患者はHA療法の開始を遅らせたり、完全に断念したりすることがあります。治療費の高額さと保険適用の少なさは、しばしばアクセスを制限し、治療の格差を生み出しています。こうした経済的課題への対処は、より多くの患者がHA療法を受けられるようにし、より多くの人々がこの効果的な膝関節症治療の恩恵を受けられるようにするために不可欠です。

例えば、

  • 2024年2月、Pain Physician誌の調査結果によると、HA注射を受けた患者は、特に複数回の注射を受けた患者は、コルチコステロイド（CS）注射を受けた患者や注射を受けなかった患者と比較して、平均費用が著しく高かったことが示されています。さらに、人工膝関節全置換術（TKA）を受けた患者は、HA治療の費用が高く、この治療法に伴う経済的障壁が浮き彫りになっています。
  • サノフィ、エノビス、ビオビコによると、Synvisc One（232.81米ドル）やBiolevox Ha（323.53米ドル）といった膝関節炎に対するヒアルロン酸（HA）療法は高額なため、アクセスが制限されています。多くの患者は、特に保険に加入していない場合は、費用負担に苦労しています。これらの治療へのアクセスを改善するには、より低コストの選択肢、より広範な適用範囲、そして価格改革が不可欠です。
  • ヒアルロン酸（HA）注射の高額な費用と保険適用の少なさは、多くの変形性膝関節症患者にとって大きな障壁となっています。複数回の注射が必要となることなど、こうした経済的な問題から、疼痛緩和と関節機能改善という効果が実証されているにもかかわらず、患者はHA療法の開始を遅らせたり、断念したりしてしまうことがよくあります。この治療法へのアクセスを向上させ、より多くの人々がその恩恵を受けられるようにするためには、こうした費用関連の問題に対処することが不可欠です。保険適用範囲の拡大と自己負担額の削減は、HA療法へのアクセスを向上させ、最終的には変形性膝関節症に苦しむ人々のケアの質の向上につながります。

膝関節炎治療におけるヒアルロン酸市場 市場展望

市場は、基礎タイプ、製品タイプ、吸収部位、年齢層、供給源、配送方法、性別、流通チャネルに基づいてセグメント化されています。

セグメンテーション

サブセグメンテーション

製品タイプ別
  • 製品タイプ
    • （単回注射（単相性）
    • 3回注射療法（三相性）
    • 5回注射療法（五相性）

処方別
  • 処方
    • 架橋ヒアルロン酸
    • 非架橋ヒアルロン酸

分子量別
  • 分子量
    • 高分子量（HMW）HA
    • 低分子量（LMW）HA
    • 中分子量HA

治療目標別

 
  • 治療目標
    • 粘性補充療法
    • 抗炎症作用と痛みの軽減
    • 軟骨の保護と再生

エンドユーザー別
  • エンドユーザー
    • 病院
    • 整形外科クリニック
    • 外来手術センター
    • 専門疼痛管理センター

流通チャネル別
  • 流通チャネル
    • 直接入札 
    • 小売薬局とオンライン薬局
    • その他

膝関節炎治療市場におけるヒアルロン酸市場

Hyaluronic Acid Market for Knee Osteoarthritis Treatment Market Regional Analysis

“North America is the Dominant Region in the Hyaluronic Acid Market for Knee Osteoarthritis Treatment”

  • North America leads the Hyaluronic Acid Market for Knee Osteoarthritis Treatment, supported by its advanced healthcare infrastructure, early adoption of non-surgical joint therapies, and the strong presence of key market players.
  • The U.S. holds a major market share due to the rising incidence of knee osteoarthritis, growing elderly population, and increasing preference for minimally invasive treatments like intra-articular hyaluronic acid injections.
  • Favorable reimbursement policies, well-established regulatory frameworks, and increased healthcare spending further contributes to the market's growth in the region.
  • Additionally, the focus on improving patient mobility and quality of life, combined with innovations in HA formulations and delivery techniques, continues to drive market expansion across North America

“Asia-Pacific is Projected to Register the Highest Growth Rate”

  • The Asia-Pacific region is projected to witness the fastest growth in the Hyaluronic Acid Market for Knee Osteoarthritis Treatment, driven by rapidly evolving healthcare infrastructure, rising awareness of joint health, and increasing demand for minimally invasive treatment options.
  • Countries such as China, India, and Japan are emerging as key markets due to the growing geriatric population and rising prevalence of knee osteoarthritis.
  • Japan, with its well-established healthcare system and high standards of elderly care, leads in the adoption of advanced HA-based viscosupplementation therapies.
  • In China and India, large patient populations, increasing healthcare investments, and growing acceptance of non-surgical osteoarthritis treatments are fueling market expansion.
  • The presence of both domestic and international HA manufacturers, along with government initiatives to improve access to orthopedic care, further accelerates market growth across the region

膝関節炎治療市場におけるヒアルロン酸市場

Hyaluronic Acid Market for Knee Osteoarthritis Treatment Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

The Major Market Leaders Operating in the Market Are:

  • LG Chem (South Korea)
  • Bioventus LLC (U.S.)
  • Seikagaku Corporation (Japan)
  • Sanofi (France)
  • Anika Therapeutics, Inc. (U.S.)
  • IBSA Institut Biochimique SA (Switzerland)
  • Viatris (U.S.)
  • Zimmer Biomet (U.S.)
  • Fidia Farmaceutici S.p.A. (Italy)
  • Ferring Pharmaceuticals (Switzerland
  • TRB CHEMEDICA SA (Switzerland)
  • Hangzhou Singclean Medical Products Co., Ltd. (China)
  • ハンミ製薬株式会社（韓国）
  • ヴィルショウ・バイオテック（インド）
  • ユープラクシア・ファーマシューティカルズ（カナダ）

膝関節炎治療における世界のヒアルロン酸市場の最新動向

  • 2024年7月、LG化学は中国の変形性関節症治療市場に参入しました。同社は易帆製薬と提携し、変形性関節症治療薬シノビアン注射剤を中国で発売しました。これにより、同社は市場参入を果たし、ポートフォリオを拡大することができました。
  • ユープラクシア・ファーマシューティカルズは2023年5月、変形性関節症（OA）治療薬EP-104IARの第2相臨床試験における最後の患者来院を完了したと発表しました。同社は第2四半期にトップラインデータを発表する予定で、有意な疼痛緩和と患者機能の改善、そして有望な安全性プロファイルの実証が期待されています。
  • 2025年3月、IBSAは販売代理店のLunatusと提携し、サウジアラビアとUAEにおける変形性関節症治療の拡大を目指します。この戦略的提携は、疼痛管理ソリューションの強化を目的としており、変形性関節症患者における高度な治療への高まる需要に対応し、他の地域諸国にも拡大する可能性があります。
  • 2023年6月、ユープラクシア・ファーマシューティカルズは、米国食品医薬品局（FDA）が膝関節炎（OA）治療薬EP-104IARにファストトラック指定を付与したことを発表しました。この指定は、開発と規制当局による審査を迅速化し、FDAとのやり取りを迅速化することを目指しています。同社は現在、第2相試験を進めており、トップラインデータは2023年第2四半期に得られる見込みです。 

SKU-

世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする

Sample Image 画像をクリックすると拡大します
  • インタラクティブなデータ分析ダッシュボード
  • 成長の可能性が高い機会のための企業分析ダッシュボード
  • カスタマイズとクエリのためのリサーチアナリストアクセス
  • インタラクティブなダッシュボードによる競合分析
  • 最新ニュース、更新情報、トレンド分析
  • 包括的な競合追跡のためのベンチマーク分析のパワーを活用
デモのリクエスト

目次

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 MULTIVARIATE MODELLING

2.6 TREATMENT TYPE LIFELINE CURVE

2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.8 DBMR MARKET POSITION GRID

2.9 MARKET END USER COVERAGE GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTAL ANALYSIS

4.2 PORTERS FIVE FORCES ANALYSIS

4.3 AVERAGE SELLING PRICE (ASP) ANALYSIS

4.4 MICRO AND MACRO ECONOMIC FACTORS

4.5 KEY PRICING STRATEGIES

4.6 HEALTHCARE ECONOMY

4.7 PENETRATION AND GROWTH PROSPECT MAPPING

4.8 TECHNOLOGY ROADMAP

4.9 VALUE CHAIN ANALYSIS

 

5 COMPANY-WISE OVERVIEW OF INTRA-ARTICULAR HYALURONIC ACID (HA) INJECTION PRODUCTS BASED ON MOLECULAR WEIGHT -

6 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, REGULATORY FRAMEWORK

6.1 NORTH AMERICA

6.2 EUROPE

6.3 ASIA-PACIFIC

6.4 MIDDLE EAST AND AFRICA

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 INCREASING PREVALENCE OF KNEE OSTEOARTHRITIS

7.1.2 GROWING PREFERENCE FOR MINIMALLY INVASIVE AND NON-SURGICAL TREATMENT OPTIONS

7.1.3 CLINICAL VALIDATION OF HYALURONIC ACID IN OSTEOARTHRITIS TREATMENT

7.1.4 RECENT LAUNCHES OF HYALURONIC ACID FOR OSTEOARTHRITIS TREATMENT

7.2 RESTRAINTS

7.2.1 COMPETITION OF ALTERNATIVE THERAPIES FOR KNEE OSTEOARTHRITIS

7.2.2 REGULATORY CHALLENGES FACED BY THE MANUFACTURERS IN THE HYALURONIC ACID MARKET

7.3 OPPORTUNITIES

7.3.1 ADVANCEMENTS IN HYALURONIC ACID FORMULATIONS AND DELIVERY SYSTEMS

7.3.2 RAISING AWARENESS AND ACCEPTANCE OF HYALURONIC ACID FOR KNEE OSTEOARTHRITIS TREATMENT AMONG PHYSICIANS AND PATIENTS

7.3.3 THE IMPACT OF COMBINING HYALURONIC ACID WITH OTHER THERAPEUTIC OPTIONS FOR KNEE OSTEOARTHRITIS

7.4 CHALLENGES

7.4.1 COST-RELATED CHALLENGES AND ACCESSIBILITY CONCERNS FOR HYALURONIC ACID THERAPY IN KNEE OSTEOARTHRITIS

7.4.2 SHORT-TERM BENEFITS WITH LIMITED LASTING EFFICACY OF HYALURONIC ACID FOR KNEE OA

8 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE

8.1 OVERVIEW

8.2 SINGLE INJECTION (MONOPHASIC)

8.3 THREE-INJECTION REGIMEN (TRIPHASIC)

8.4 FIVE-INJECTION REGIMEN (PENTAPHASIC)

 

9 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION

9.1 OVERVIEW

9.2 CROSS-LINKED HYALURONIC ACID

9.3 NON-CROSS-LINKED HYALURONIC ACID

10 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT

10.1 OVERVIEW

10.2 HIGH MOLECULAR WEIGHT (HMW) HA

10.3 LOW MOLECULAR WEIGHT (LMW) HA

10.4 INTERMEDIATE MOLECULAR WEIGHT HA

11 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS

11.1 OVERVIEW

11.2 VISCOSUPPLEMENTATION

11.3 ANTI-INFLAMMATORY & PAIN REDUCTION

11.4 CARTILAGE PROTECTION & REGENERATION

12 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER

12.1 OVERVIEW

12.2 HOSPITALS

12.3 ORTHOPEDIC CLINICS

12.4 AMBULATORY SURGICAL CENTERS

12.5 SPECIALTY PAIN MANAGEMENT CENTERS

13 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL

13.1 OVERVIEW

13.2 DIRECT TENDER

13.3 RETAIL & ONLINE PHARMACIES

13.4 OTHERS

 

14 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION

14.1 OVERVIEW

14.2 NORTH AMERICA

14.2.1 U.S.

14.2.2 CANADA

14.2.3 MEXICO

14.3 EUROPE

14.3.1 GERMANY

14.3.2 FRANCE

14.3.3 U.K.

14.3.4 ITALY

14.3.5 SPAIN

14.3.6 RUSSIA

14.3.7 TURKEY

14.3.8 NETHERLANDS

14.3.9 SWITZERLAND

14.3.10 POLAND

14.3.11 BELGIUM

14.3.12 SWEDEN

14.3.13 AUSTRIA

14.3.14 NORWAY

14.3.15 DENMARK

14.3.16 REST OF EUROPE

14.4 ASIA-PACIFIC

14.4.1 CHINA

14.4.2 JAPAN

14.4.3 INDIA

14.4.4 SOUTH KOREA

14.4.5 AUSTRALIA

14.4.6 SINGAPORE

14.4.7 THAILAND

14.4.8 INDONESIA

14.4.9 MALAYSIA

14.4.10 TAIWAN

14.4.11 NEW ZEALAND

14.4.12 PHILIPPINES

14.4.13 VIETNAM

14.4.14 KAZAKHSTAN

14.4.15 BRUNEI

14.4.16 REST OF ASIA-PACIFIC

14.5 SOUTH AMERICA

14.5.1 BRAZIL

14.5.2 ARGENTINA

14.5.3 COLOMBIA

14.5.4 CHILE

14.5.5 PERU

14.5.6 ECUADOR

14.5.7 VENEZUELA

14.5.8 PANAMA

14.5.9 URUGUAY

14.5.10 DOMINICAN

14.5.11 REST OF SOUTH AMERICA

14.6 MIDDLE EAST AND AFRICA

14.6.1 SAUDI ARABIA

14.6.2 SOUTH AFRICA

14.6.3 UNITED ARAB EMIRATES

14.6.4 ISRAEL

14.6.5 EGYPT

14.6.6 KUWAIT

14.6.7 QATAR

14.6.8 IRAN

14.6.9 OMAN

14.6.10 ALGERIA

14.6.11 NIGERIA

14.6.12 IRAQ

14.6.13 MOROCCO

14.6.14 KENYA

14.6.15 GHANA

14.6.16 TUNISIA

14.6.17 TANZANIA

14.6.18 JORDAN

14.6.19 LIBYA

14.6.20 BAHRAIN

14.6.21 ANGOLA

14.6.22 CAMEROON

14.6.23 IVORY

14.6.24 ZIMBABWE

14.6.25 SENEGAL

14.6.26 MAURITANIA

14.6.27 TOGO

14.6.28 MAURITIUS

14.6.29 BOTSWANA

14.6.30 REST OF MIDDLE EAST AND AFRICA

15 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: COMPANY LANDSCAPE

15.1 COMPANY SHARE ANALYSIS: GLOBAL

15.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

15.3 COMPANY SHARE ANALYSIS: EUROPE

15.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

16 SWOT ANALYSIS

17 COMPANY PROFILE

17.1 LG CHEM

17.1.1 COMPANY SNAPSHOT

17.1.2 REVENUE ANALYSIS

17.1.3 COMPANY SHARE ANALYSIS

17.1.4 PRODUCT PORTFOLIO

17.1.5 RECENT DEVELOPMENTS

17.2 BIOVENTUS

17.2.1 COMPANY SNAPSHOT

17.2.2 REVENUE ANALYSIS

17.2.3 COMPANY SHARE ANALYSIS

17.2.4 PRODUCT PORTFOLIO

17.2.5 RECENT DEVELOPMENT

17.3 SEIKAGAKU CORPORATION

17.3.1 COMPANY SNAPSHOT

17.3.2 REVENUE ANALYSIS

17.3.3 COMPANY SHARE ANALYSIS

17.3.4 PRODUCT PORTFOLIO

17.3.5 RECENT DEVELOPMENT

17.4 SANOFI

17.4.1 COMPANY SNAPSHOT

17.4.2 REVENUE ANALYSIS

17.4.3 COMPANY SHARE ANALYSIS

17.4.4 PRODUCT PORTFOLIO

17.4.5 RECENT DEVELOPMENT

 

17.5 ANIKA THERAPEUTICS, INC.

17.5.1 COMPANY SNAPSHOT

17.5.2 REVENUE ANALYSIS

17.5.3 COMPANY SHARE ANALYSIS

17.5.4 PRODUCT PORTFOLIO

17.5.5 RECENT DEVELOPMENT

17.6 EUPRAXIA PHARMACEUTICALS

17.6.1 COMPANY SNAPSHOT

17.6.2 REVENUE ANALYSIS

17.6.3 PRODUCT PORTFOLIO

17.6.4 RECENT DEVELOPMENT

17.7 FIDIA FARMACEUTICI S.P.A.

17.7.1 COMPANY SNAPSHOT

17.7.2 REVENUE ANALYSIS

17.7.3 PRODUCT PORTFOLIO

17.7.4 RECENT DEVELOPMENT

17.8 FERRING

17.8.1 COMPANY SNAPSHOT

17.8.2 PRODUCT PORTFOLIO

17.8.3 RECENT DEVELOPMENT

17.9 HANGZHOU SINGCLEAN MEDICAL PRODUCTS CO.,LTD.

17.9.1 COMPANY SNAPSHOT

17.9.2 PRODUCT PORTFOLIO

17.9.3 RECENT DEVELOPMENTS

17.1 HANMI PHARM.CO., LTD

17.10.1 COMPANY SNAPSHOT

17.10.2 REVENUE ANALYSIS

17.10.3 PRODUCT PORTFOLIO

17.10.4 RECENT DEVELOPMENT

17.11 IBSA INSTITUT BIOCHIMIQUE SA.

17.11.1 COMPANY SNAPSHOT

17.11.2 PRODUCT PORTFOLIO

17.11.3 RECENT DEVELOPMENT

17.12 TRB CHEMEDICA INTERNATIONAL SA

17.12.1 COMPANY SNAPSHOT

17.12.2 PRODUCT PORTFOLIO

17.12.3 RECENT DEVELOPMENTS

 

17.13 VIATRIS INC.

17.13.1 COMPANY SNAPSHOT

17.13.2 REVENUE ANALYSIS

17.13.3 PRODUCT PORTFOLIO

17.13.4 RECENT DEVELOPMENT

17.14 VIRCHOW BIOTECH

17.14.1 COMPANY SNAPSHOT

17.14.2 PRODUCT PORTFOLIO

17.14.3 RECENT DEVELOPMENTS

17.15 ZIMMER BIOMET

17.15.1 COMPANY SNAPSHOT

17.15.2 REVENUE ANALYSIS

17.15.3 PRODUCT PORTFOLIO

17.15.4 RECENT DEVELOPMENT

18 QUESTIONNAIRE

19 RELATED REPORTS

表のリスト

TABLE 1 COMPANY PRODUCT AND ADVANCEMENT IN FORMULATION

TABLE 2 COMPANY PRODUCT AND COMBINATION THERAPY

TABLE 3 PRICE OF THE HYALURONIC ACID INJECTION

TABLE 4 COMPANY PRODUCT AND LASTING EFFICACY

TABLE 5 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 6 GLOBAL SINGLE INJECTION (MONOPHASIC) IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 7 GLOBAL THREE-INJECTION REGIMEN (TRIPHASIC) IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 8 GLOBAL FIVE-INJECTION REGIMEN (PENTAPHASIC IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 9 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 10 GLOBAL CROSS-LINKED HYALURONIC ACID IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 11 GLOBAL NON-CROSS-LINKED HYALURONIC ACID IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 12 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 13 GLOBAL HIGH MOLECULAR WEIGHT (HMW) HA IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 14 GLOBAL LOW MOLECULAR WEIGHT (LMW) HA IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 15 GLOBAL INTERMEDIATE MOLECULAR WEIGHT HA IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 16 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 17 GLOBAL VISCOSUPPLEMENTATION IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 18 GLOBAL ANTI-INFLAMMATORY & PAIN REDUCTION IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 19 GLOBAL CARTILAGE PROTECTION & REGENERATION IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 20 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 21 GLOBAL HOSPITALS IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 22 GLOBAL ORTHOPEDIC CLINICS IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 23 GLOBAL AMBULATORY SURGICAL CENTERS IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 24 GLOBAL SPECIALTY PAIN MANAGEMENT CENTERS IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 25 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 26 GLOBAL DIRECT TENDER IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 27 GLOBAL RETAIL & ONLINE PHARMACIES IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 28 GLOBAL OTHERS IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 29 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 30 NORTH AMERICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 31 NORTH AMERICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 32 NORTH AMERICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 33 NORTH AMERICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 34 NORTH AMERICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 35 NORTH AMERICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 36 NORTH AMERICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 37 U.S. HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 38 U.S. HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 39 U.S. HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 40 U.S. HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 41 U.S. HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 42 U.S. HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 43 CANADA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 44 CANADA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 45 CANADA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 46 CANADA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 47 CANADA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 48 CANADA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 49 MEXICO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 50 MEXICO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 51 MEXICO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 52 MEXICO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 53 MEXICO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 54 MEXICO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 55 EUROPE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 56 EUROPE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 57 EUROPE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 58 EUROPE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 59 EUROPE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 60 EUROPE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 61 EUROPE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 62 GERMANY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 63 GERMANY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 64 GERMANY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 65 GERMANY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 66 GERMANY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 67 GERMANY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 68 FRANCE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 69 FRANCE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 70 FRANCE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 71 FRANCE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 72 FRANCE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 73 FRANCE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 74 U.K. HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 75 U.K. HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 76 U.K. HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 77 U.K. HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 78 U.K. HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 79 U.K. HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 80 ITALY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 81 ITALY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 82 ITALY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 83 ITALY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 84 ITALY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 85 ITALY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 86 SPAIN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 87 SPAIN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 88 SPAIN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 89 SPAIN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 90 SPAIN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 91 SPAIN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 92 RUSSIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 93 RUSSIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 94 RUSSIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 95 RUSSIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 96 RUSSIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 97 RUSSIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 98 TURKEY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 99 TURKEY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 100 TURKEY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 101 TURKEY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 102 TURKEY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 103 TURKEY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 104 NETHERLANDS HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 105 NETHERLANDS HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 106 NETHERLANDS HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 107 NETHERLANDS HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 108 NETHERLANDS HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 109 NETHERLANDS HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 110 SWITZERLAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 111 SWITZERLAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 112 SWITZERLAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 113 SWITZERLAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 114 SWITZERLAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 115 SWITZERLAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 116 POLAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 117 POLAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 118 POLAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 119 POLAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 120 POLAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 121 POLAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 122 BELGIUM HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 123 BELGIUM HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 124 BELGIUM HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 125 BELGIUM HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 126 BELGIUM HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 127 BELGIUM HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 128 SWEDEN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 129 SWEDEN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 130 SWEDEN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 131 SWEDEN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 132 SWEDEN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 133 SWEDEN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 134 AUSTRIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 135 AUSTRIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 136 AUSTRIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 137 AUSTRIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 138 AUSTRIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 139 AUSTRIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 140 NORWAY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 141 NORWAY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 142 NORWAY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 143 NORWAY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 144 NORWAY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 145 NORWAY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 146 DENMARK HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 147 DENMARK HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 148 DENMARK HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 149 DENMARK HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 150 DENMARK HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 151 DENMARK HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 152 REST OF EUROPE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 153 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 154 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 155 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 156 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 157 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 158 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 159 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 160 CHINA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 161 CHINA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 162 CHINA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 163 CHINA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 164 CHINA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 165 CHINA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 166 JAPAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 167 JAPAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 168 JAPAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 169 JAPAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 170 JAPAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 171 JAPAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 172 INDIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 173 INDIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 174 INDIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 175 INDIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 176 INDIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 177 INDIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 178 SOUTH KOREA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 179 SOUTH KOREA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 180 SOUTH KOREA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 181 SOUTH KOREA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 182 SOUTH KOREA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 183 SOUTH KOREA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 184 AUSTRALIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 185 AUSTRALIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 186 AUSTRALIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 187 AUSTRALIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 188 AUSTRALIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 189 AUSTRALIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 190 SINGAPORE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 191 SINGAPORE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 192 SINGAPORE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 193 SINGAPORE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 194 SINGAPORE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 195 SINGAPORE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 196 THAILAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 197 THAILAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 198 THAILAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 199 THAILAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 200 THAILAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 201 THAILAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 202 INDONESIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 203 INDONESIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 204 INDONESIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 205 INDONESIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 206 INDONESIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 207 INDONESIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 208 MALAYSIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 209 MALAYSIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 210 MALAYSIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 211 MALAYSIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 212 MALAYSIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 213 MALAYSIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 214 TAIWAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 215 TAIWAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 216 TAIWAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 217 TAIWAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 218 TAIWAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 219 TAIWAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 220 NEW ZEALAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 221 NEW ZEALAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 222 NEW ZEALAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 223 NEW ZEALAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 224 NEW ZEALAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 225 NEW ZEALAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 226 PHILIPPINES HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 227 PHILIPPINES HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 228 PHILIPPINES HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 229 PHILIPPINES HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 230 PHILIPPINES HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 231 PHILIPPINES HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 232 VIETNAM HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 233 VIETNAM HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 234 VIETNAM HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 235 VIETNAM HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 236 VIETNAM HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 237 VIETNAM HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 238 KAZAKHSTAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 239 KAZAKHSTAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 240 KAZAKHSTAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 241 KAZAKHSTAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 242 KAZAKHSTAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 243 KAZAKHSTAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 244 BRUNEI HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 245 BRUNEI HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 246 BRUNEI HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 247 BRUNEI HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 248 BRUNEI HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 249 BRUNEI HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 250 REST OF ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 251 SOUTH AMERICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 252 SOUTH AMERICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 253 SOUTH AMERICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 254 SOUTH AMERICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 255 SOUTH AMERICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 256 SOUTH AMERICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 257 SOUTH AMERICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 258 BRAZIL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 259 BRAZIL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 260 BRAZIL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 261 BRAZIL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 262 BRAZIL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 263 BRAZIL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 264 ARGENTINA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 265 ARGENTINA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 266 ARGENTINA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 267 ARGENTINA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 268 ARGENTINA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 269 ARGENTINA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 270 COLOMBIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 271 COLOMBIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 272 COLOMBIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 273 COLOMBIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 274 COLOMBIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 275 COLOMBIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 276 CHILE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 277 CHILE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 278 CHILE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 279 CHILE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 280 CHILE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 281 CHILE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 282 PERU HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 283 PERU HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 284 PERU HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 285 PERU HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 286 PERU HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 287 PERU HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 288 ECUADOR HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 289 ECUADOR HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 290 ECUADOR HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 291 ECUADOR HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 292 ECUADOR HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 293 ECUADOR HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 294 VENEZUELA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 295 VENEZUELA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 296 VENEZUELA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 297 VENEZUELA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 298 VENEZUELA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 299 VENEZUELA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 300 PANAMA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 301 PANAMA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 302 PANAMA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 303 PANAMA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 304 PANAMA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 305 PANAMA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 306 URUGUAY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 307 URUGUAY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 308 URUGUAY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 309 URUGUAY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 310 URUGUAY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 311 URUGUAY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 312 DOMINICAN REPUBLIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 313 DOMINICAN REPUBLIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 314 DOMINICAN REPUBLIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 315 DOMINICAN REPUBLIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 316 DOMINICAN REPUBLIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 317 DOMINICAN REPUBLIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 318 REST OF SOUTH AMERICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 319 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 320 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 321 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 322 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 323 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 324 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 325 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 326 SAUDI ARABIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 327 SAUDI ARABIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 328 SAUDI ARABIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 329 SAUDI ARABIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 330 SAUDI ARABIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 331 SAUDI ARABIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 332 SOUTH AFRICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 333 SOUTH AFRICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 334 SOUTH AFRICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 335 SOUTH AFRICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 336 SOUTH AFRICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 337 SOUTH AFRICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 338 UNITED ARAB EMIRATES HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 339 UNITED ARAB EMIRATES HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 340 UNITED ARAB EMIRATES HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 341 UNITED ARAB EMIRATES HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 342 UNITED ARAB EMIRATES HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 343 UNITED ARAB EMIRATES HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 344 ISRAEL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 345 ISRAEL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 346 ISRAEL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 347 ISRAEL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 348 ISRAEL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 349 ISRAEL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 350 EGYPT HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 351 EGYPT HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 352 EGYPT HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 353 EGYPT HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 354 EGYPT HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 355 EGYPT HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 356 KUWAIT HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 357 KUWAIT HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 358 KUWAIT HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 359 KUWAIT HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 360 KUWAIT HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 361 KUWAIT HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 362 QATAR HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 363 QATAR HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 364 QATAR HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 365 QATAR HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 366 QATAR HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 367 QATAR HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 368 IRAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 369 IRAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 370 IRAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 371 IRAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 372 IRAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 373 IRAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 374 OMAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 375 OMAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 376 OMAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 377 OMAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 378 OMAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 379 OMAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 380 ALGERIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 381 ALGERIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 382 ALGERIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 383 ALGERIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 384 ALGERIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 385 ALGERIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 386 NIGERIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 387 NIGERIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 388 NIGERIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 389 NIGERIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 390 NIGERIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 391 NIGERIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 392 IRAQ HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 393 IRAQ HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 394 IRAQ HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 395 IRAQ HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 396 IRAQ HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 397 IRAQ HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 398 MOROCCO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 399 MOROCCO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 400 MOROCCO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 401 MOROCCO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 402 MOROCCO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 403 MOROCCO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 404 KENYA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 405 KENYA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 406 KENYA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 407 KENYA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 408 KENYA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 409 KENYA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 410 GHANA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 411 GHANA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 412 GHANA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 413 GHANA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 414 GHANA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 415 GHANA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 416 TUNISIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 417 TUNISIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 418 TUNISIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 419 TUNISIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 420 TUNISIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 421 TUNISIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 422 TANZANIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 423 TANZANIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 424 TANZANIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 425 TANZANIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 426 TANZANIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 427 TANZANIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 428 JORDAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 429 JORDAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 430 JORDAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 431 JORDAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 432 JORDAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 433 JORDAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 434 LIBYA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 435 LIBYA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 436 LIBYA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 437 LIBYA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 438 LIBYA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 439 LIBYA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 440 BAHRAIN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 441 BAHRAIN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 442 BAHRAIN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 443 BAHRAIN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 444 BAHRAIN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 445 BAHRAIN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 446 ANGOLA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 447 ANGOLA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 448 ANGOLA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 449 ANGOLA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 450 ANGOLA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 451 ANGOLA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 452 CAMEROON HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 453 CAMEROON HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 454 CAMEROON HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 455 CAMEROON HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 456 CAMEROON HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 457 CAMEROON HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 458 IVORY COAST HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 459 IVORY COAST HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 460 IVORY COAST HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 461 IVORY COAST HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 462 IVORY COAST HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 463 IVORY COAST HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 464 ZIMBABWE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 465 ZIMBABWE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 466 ZIMBABWE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 467 ZIMBABWE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 468 ZIMBABWE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 469 ZIMBABWE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 470 SENEGAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 471 SENEGAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 472 SENEGAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 473 SENEGAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 474 SENEGAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 475 SENEGAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 476 MAURITANIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 477 MAURITANIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 478 MAURITANIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 479 MAURITANIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 480 MAURITANIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 481 MAURITANIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 482 TOGO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 483 TOGO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 484 TOGO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 485 TOGO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 486 TOGO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 487 TOGO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 488 MAURITIUS HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 489 MAURITIUS HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 490 MAURITIUS HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 491 MAURITIUS HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 492 MAURITIUS HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 493 MAURITIUS HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 494 BOTSWANA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 495 BOTSWANA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 496 BOTSWANA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 497 BOTSWANA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 498 BOTSWANA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 499 BOTSWANA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 500 REST OF MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

図表一覧

FIGURE 1 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: SEGMENTATION

FIGURE 2 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: DATA TRIANGULATION

FIGURE 3 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: DROC ANALYSIS

FIGURE 4 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: REGIONAL MARKET ANALYSIS

FIGURE 5 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: LIFELINE CURVE

FIGURE 7 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: INTERVIEW DEMOGRAPHICS

FIGURE 8 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: DBMR MARKET POSITION GRID

FIGURE 9 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: MARKET END USER COVERAGE GRID

FIGURE 10 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: VENDOR SHARE ANALYSIS

FIGURE 11 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: SEGMENTATION

FIGURE 12 THREE SEGMENTS COMPRISE THE GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE

FIGURE 13 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT EXECUTIVE SUMMARY

FIGURE 14 STRATEGIC DECISIONS

FIGURE 15 RISING PREVALENCE OF KNEE OSTEOARTHRITIS IS EXPECTED TO DRIVE THE GROWTH OF GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT FROM 2025 TO 2032

FIGURE 16 THE SINGLE INJECTION (MONOPHASIC) SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT IN 2025 - 2032

FIGURE 17 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2025 TO 2032

FIGURE 18 ASIA-PACIFIC IS THE FASTEST-GROWING MARKET FOR GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT IN THE FORECAST PERIOD OF 2025 TO 2032

FIGURE 19 DROC ANALYSIS

FIGURE 20 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY PRODUCT TYPE, 2024

FIGURE 21 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY PRODUCT TYPE, 2025-2032 (USD THOUSAND)

FIGURE 22 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY PRODUCT TYPE, CAGR (2025-2032)

FIGURE 23 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 24 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY FORMULATION, 2024

FIGURE 25 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY FORMULATION, 2025-2032 (USD THOUSAND)

FIGURE 26 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY FORMULATION, CAGR (2025-2032)

FIGURE 27 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY FORMULATION, LIFELINE CURVE

FIGURE 28 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY MOLECULAR WEIGHT, 2024

FIGURE 29 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY MOLECULAR WEIGHT, 2025-2032 (USD THOUSAND)

FIGURE 30 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY MOLECULAR WEIGHT, CAGR (2025-2032)

FIGURE 31 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY MOLECULAR WEIGHT, LIFELINE CURVE

FIGURE 32 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY TREATMENT GOALS, 2024

FIGURE 33 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY TREATMENT GOALS, 2025-2032 (USD THOUSAND)

FIGURE 34 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY TREATMENT GOALS, CAGR (2025-2032)

FIGURE 35 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY TREATMENT GOALS, LIFELINE CURVE

FIGURE 36 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY END USER, 2024

FIGURE 37 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY END USER, 2025-2032 (USD THOUSAND)

FIGURE 38 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY END USER, CAGR (2025-2032)

FIGURE 39 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY END USER, LIFELINE CURVE

FIGURE 40 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY DISTRIBUTION CHANNEL, 2024

FIGURE 41 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY DISTRIBUTION CHANNEL, 2025-2032 (USD THOUSAND)

FIGURE 42 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY DISTRIBUTION CHANNEL, CAGR (2025-2032)

FIGURE 43 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 44 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: SNAPSHOT (2024)

FIGURE 45 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: COMPANY SHARE 2024 (%)

FIGURE 46 NORTH AMERICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: COMPANY SHARE 2024 (%)

FIGURE 47 EUROPE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: COMPANY SHARE 2024 (%)

FIGURE 48 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: COMPANY SHARE 2024 (%)

詳細情報を見る Right Arrow

調査方法

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。

DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。

カスタマイズ可能

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。

Frequently Asked Questions

市場は 膝関節症治療のためのヒアルロン酸の世界市場：市場区分、製品タイプ別（単回注入（モノファジック）、3回注入レジメン（トリファジック）、5回注入レジメン（ペンタファジック））、処方別（架橋ヒアルロン酸、非架橋ヒアルロン酸）、分子量別（高分子量（HMW）ヒアルロン酸、低分子量（LMW）ヒアルロン酸、中分子量ヒアルロン酸）、治療目標別（粘性補充療法、抗炎症および鎮痛、軟骨保護および再生）、エンドユーザー別（病院、整形外科クリニック、外来手術センター、専門疼痛管理センター）、流通チャネル別（直接入札、小売およびオンライン薬局、その他）、国別（米国、カナダ、メキシコ、ドイツ、フランス、英国、イタリア、ロシア、スペイン、トルコ、オランダ、スイス、ベルギー、スウェーデン、オーストリア、デンマーク、ノルウェー、ポーランド、その他のヨーロッパ諸国、中国、インド、日本、韓国、オーストラリア、インドネシア、タイ、マレーシア、ベトナム、フィリピン、台湾、シンガポール、ニュージーランド、フィリピン、カザフスタン、ブルネイ、その他のアジア太平洋諸国、サウジアラビア、南アフリカ、エジプト、UAE、イスラエル、クウェート、カタール、イラン、オマーン、アルジェリア、ナイジェリア、イラク、モロッコ、ケニア、ガーナ、チュニジア、タンザニア、ヨルダン、リビア、バーレーン、アンゴラ、カメルーン、コートジボワール、ジンバブエ、セネガル、モーリタニア、トーゴ、モーリシャス、ボツワナ、その他の中東およびアフリカ諸国、ブラジル、アルゼンチン、チリ、ペルー、コロンビア、エクアドル、ベネズエラ、パナマ、ウルグアイ、ドミニカ共和国、その他の南米諸国 - 2032年までの業界動向と予測 に基づいて分類されます。
膝関節炎治療におけるヒアルロン酸の世界市場の規模は2024年にUSD 2.28 USD Billionと推定されました。
膝関節炎治療におけるヒアルロン酸の世界市場は2025年から2032年の予測期間にCAGR 8.3%で成長すると見込まれています。
市場で活動している主要プレーヤーはLG Chem, Bioventus LLC, Seikagaku Corporationです。

関連ページを閲覧する

Banner
Testimonial
Image
David Manning - Thermo Fisher Scientific Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.
Image
Manager - Market Analytics, Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Image
Business Development Manager, (Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Image
Business Intelligence and Analytics, Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Image
Competition Analyst, Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Image
Marketing Director, Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

Image
COO, A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Image
Marketing Director, Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Image
Product manager, Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Image
Investor relations, GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Image
Market Analyst, Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Image
Andrew - Senior Global Marketing Manager, Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Image
Amarildo - Manager, Global Strategic Alignment MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Image
Tor Hammer Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Image
Tommaso Finocchiaro Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Image
Yuki Kopyl (Asian Business Development Department) UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future